| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/30/2008 | EP1948615A2 Compounds useful in therapy |
| 07/30/2008 | EP1948607A2 Cyclopropyl amines as modulators of the histamine h3 receptor |
| 07/30/2008 | EP1948606A1 3, 5-disubstituted phenyl-piperidines as modulators of dopamine neurotransmission |
| 07/30/2008 | EP1948605A2 Modulators of the h3 receptor useful for the treatment of disorders related thereto |
| 07/30/2008 | EP1948604A1 Indole compounds having c4-acidic substituents and use thereof as phospholipase-a2 inhibitors |
| 07/30/2008 | EP1948603A1 Tetrahydroindole derivatives for treatment of alzheimer's disease |
| 07/30/2008 | EP1948602A2 Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitors |
| 07/30/2008 | EP1948600A2 Liver targeted conjugates |
| 07/30/2008 | EP1948597A1 Derivatives for modulation of ion channels |
| 07/30/2008 | EP1948596A2 Soft anticholinergic esters |
| 07/30/2008 | EP1948593A2 Process for the preparation of tamsulosin and related compounds |
| 07/30/2008 | EP1948320A2 Skin care composition for accelerated production of collagen proteins and method of fabricating same |
| 07/30/2008 | EP1948245A2 Compositions and their uses for gene therapy of bone conditions |
| 07/30/2008 | EP1948244A2 Pharmaceutical composition and method for regulating abnormal cellular proliferation |
| 07/30/2008 | EP1948238A1 Compositions and methods for the treatment of addiction and other neuropsychiatric disorders |
| 07/30/2008 | EP1948237A1 USE OF ß-1,3 (4)-ENDOGLUCANOHYDROLASE, ß-1,3 (4) GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION |
| 07/30/2008 | EP1948236A2 Methods and compositions for treatment of skin |
| 07/30/2008 | EP1948225A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase as a vehicle for cancer treatment |
| 07/30/2008 | EP1948224A1 Stable formulation of amorphous perindopril salts, a process for their preparation, especially industrial preparation, and their use in the therapy of hypertension |
| 07/30/2008 | EP1948205A2 Process for metabolic control and high solute clearance and solutions for use therein |
| 07/30/2008 | EP1948203A2 Aromatic di-acid-containing poly (ester amide) polymers and methods of use |
| 07/30/2008 | EP1948202A2 Topical skin barriers and methods of evaluation thereof |
| 07/30/2008 | EP1948201A1 Pharmaceutical compositions comprising polymeric binders with non-hydrolysable covalent bonds and their use in treating celiac disease |
| 07/30/2008 | EP1948200A2 Wound-healing composition |
| 07/30/2008 | EP1948199A1 Pharmaceutical compositions for the administration of aptamers |
| 07/30/2008 | EP1948198A2 Serum response factor and myocardin control alzheimer cerebral amyloid angiopathy |
| 07/30/2008 | EP1948197A2 Devices, systems and methods for improving memory and/or cognitive function through brain delivery of sirna |
| 07/30/2008 | EP1948196A2 Use of tetraorganosilicon compounds |
| 07/30/2008 | EP1948195A2 Improved methods of using phosphoantigen for the treatment of cancer |
| 07/30/2008 | EP1948194A2 Use of clodronic acid for the treatment of navicular syndrome |
| 07/30/2008 | EP1948193A2 Aminopyrimidines useful as kinase inhibitors |
| 07/30/2008 | EP1948192A2 Therapeutic uses of steroidal compounds |
| 07/30/2008 | EP1948191A2 Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties |
| 07/30/2008 | EP1948190A2 Pharmaceutical use of substituted amides |
| 07/30/2008 | EP1948189A1 Use of aza-phenylalanine compounds for treating cardiac arrhythmia |
| 07/30/2008 | EP1948188A2 Inhibitors of akt activity |
| 07/30/2008 | EP1948187A2 Chemical compounds |
| 07/30/2008 | EP1948186A1 Aerosolformulation for inhalation |
| 07/30/2008 | EP1948185A2 Inhibitors of akt activity |
| 07/30/2008 | EP1948184A2 Reducing cellular cholesterol levels and/or treating or preventing phospholipidosis |
| 07/30/2008 | EP1948183A1 Compositions for the treatment and prevention of heart disease and methods of using same |
| 07/30/2008 | EP1948182A1 Method for treating neuronal and non-neuronal pain |
| 07/30/2008 | EP1948181A1 Dosage form for hormonal contraception |
| 07/30/2008 | EP1948180A1 Combination treatment of cancer comprising egfr/her2 inhibitors |
| 07/30/2008 | EP1948179A1 Quinazoline derivatives for the treatment of cancer diseases |
| 07/30/2008 | EP1948178A2 Methods of treating atrial fibrillation with p38 inhibitor compounds |
| 07/30/2008 | EP1948177A1 Use of flibanserin for the treatment of pre-menopausal sexual desire disorders |
| 07/30/2008 | EP1948176A1 Diaryl ureas for treating pulmonary hypertension |
| 07/30/2008 | EP1948175A1 Treatment of the symptoms of bladder irritation |
| 07/30/2008 | EP1948174A2 Fluridone as an anti-inflammatory agent |
| 07/30/2008 | EP1948173A2 Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods |
| 07/30/2008 | EP1948172A1 Diaryl ureas for treating diabetic neuropathy |
| 07/30/2008 | EP1948171A1 New method for treating cancer based on the modulation of calcineurin |
| 07/30/2008 | EP1948170A1 Diaryl urea for treating pulmonary hypertension |
| 07/30/2008 | EP1948169A2 Diazonamide a analog |
| 07/30/2008 | EP1948168A2 Compositions and treatments for inhibiting kinase and/or hmg-coa reductase |
| 07/30/2008 | EP1948167A1 Compositions of phosphodiesterase type iv inhibitors |
| 07/30/2008 | EP1948166A1 Carbazole derivatives as functional 5-ht6 ligands |
| 07/30/2008 | EP1948165A1 Pharmaceutical combination comprising atorvastatin derivatives |
| 07/30/2008 | EP1948164A1 Pharmaceutical compositions of muscarinic receptor antagonists |
| 07/30/2008 | EP1948163A2 Methods for treating disorders associated with hyperlipidemia in a mammal |
| 07/30/2008 | EP1948162A1 Pharmaceutical compositions containing erythrine mulungu derivatives and processes for their production |
| 07/30/2008 | EP1948160A1 Treatment of mitochondria-related diseases and improvement of age-related metabolic deficits |
| 07/30/2008 | EP1948159A2 Pharmaceutical gallium compositions and methods |
| 07/30/2008 | EP1948158A1 Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor |
| 07/30/2008 | EP1948157A2 Compositions for treating dermatological and neurological disorders |
| 07/30/2008 | EP1948156A2 Composition with docosapentaenoic acid |
| 07/30/2008 | EP1948155A2 Pharmaceutical compositions comprising droxidopa |
| 07/30/2008 | EP1948154A1 System and method for the prevention of bacterial and fungal infections including urinary tract infections (uti) using n-halogenated amino acids |
| 07/30/2008 | EP1948153A2 Treatment of symptoms of parkinson`s disease |
| 07/30/2008 | EP1948152A2 Compounds for the treatment of metabolic disorders |
| 07/30/2008 | EP1948151A1 Compositions for peritoneal dialysis |
| 07/30/2008 | EP1948150A2 Combinations of metformin and meglitinide |
| 07/30/2008 | EP1948149A2 Formulation comprising metformin and vildagliptin |
| 07/30/2008 | EP1948148A2 Formulations of fispemifene |
| 07/30/2008 | EP1948147A2 Compositions useful for prevention and treatment of common cold and influenza-like symptoms |
| 07/30/2008 | EP1948146A2 Novel multi-cyclic compounds and their use |
| 07/30/2008 | EP1948145A2 Protection of oxidizable agents |
| 07/30/2008 | EP1948144A2 Diaryl urea for treating diabetic neuropathy |
| 07/30/2008 | EP1948140A1 Enteric soft capsule comprising valproic acid |
| 07/30/2008 | EP1948137A2 Pharmaceutical formulations containing 5-cyclopropyl-2(4-fluorophenyl)-6-(2-hydroxyethyl)(methylsulfonyl) amino-n-methyl-1-benzofuran-3-carboxamide and method of making same |
| 07/30/2008 | EP1948132A1 Zolpidem tablets |
| 07/30/2008 | EP1948131A2 Pharmaceutical composition free from dexpanthenol, calcium ions, and phosphate, and use of calcium chelating agent and ophthalmologically compatible viscosity regulator |
| 07/30/2008 | EP1948130A2 Topical pharmaceutical foam composition |
| 07/30/2008 | EP1947943A2 Small molecule inhibitors of hiv-1 capsid assembly |
| 07/30/2008 | EP1947938A2 Macrocyclic formulations for transmembrane drug delivery |
| 07/30/2008 | EP1846000A4 Pharmaceutical compositions containing bisphosphonate for improving oral absorption |
| 07/30/2008 | EP1809297B1 Imidazo[1,5a]triazolo[1,5d]benzodiazepine derivatives for the treatment of cognitive disorders |
| 07/30/2008 | EP1791535B1 Novel tellurium compounds and their use as immunomodulators |
| 07/30/2008 | EP1776377B1 Novel steroid agonist for fxr |
| 07/30/2008 | EP1768673B1 Orally disintegrating pharmaceutical composition comprising risperidone |
| 07/30/2008 | EP1761514B1 Novel tetracyclic tetrahydrofuran derivatives |
| 07/30/2008 | EP1758470B1 Prebiotic preparation |
| 07/30/2008 | EP1747204B1 Tri-substituted ureas as cytokine inhibitors |
| 07/30/2008 | EP1742952B1 (poly) aminoacetamide derivatives of epipodophyllotoxin, their process of preparation and their applications in therapeutics as anticancer agents |
| 07/30/2008 | EP1740191A4 Use of equol for treating skin diseases |
| 07/30/2008 | EP1737462B1 Pyrimidines with tie2 (tek) activity |
| 07/30/2008 | EP1716152B1 Fused hetrocyclic compounds and their use as metabotropic receptor antagonists for the treatment of gastrointestinal disorders |
| 07/30/2008 | EP1713475B1 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 07/30/2008 | EP1685113B1 Substituted pyrazoles as ppar agonists |